Trump’s Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It’s ‘Difficult’ To Predict As Drugmakers Have ‘Complex Supply Chains’

All NewsJuly 16, 2025

Barclays has said that it’s hard to predict which firm would be affected the most by pharma tariffs, except for Novo Nordisk.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent